Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Onpattro Generic Name & Formulations
Legal Class
Rx
General Description
Patisiran 10mg/5mL (2mg/mL); per vial; lipid complex for IV infusion after filtration and dilution; preservative-free.
Pharmacological Class
Transthyretin-directed small interfering RNA.
How Supplied
Single-dose vial—1
Manufacturer
Generic Availability
NO
Onpattro Indications
Indications
Polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
Onpattro Dosage and Administration
Adult
See full labeling. Premedicate with IV corticosteroid, oral acetaminophen, IV H1- and H2-blocker on the day of Onpattro infusion
at least 60mins prior to initiation; may reduce corticosteroid as needed, if related adverse reactions occur. Give as IV infusion over ~80mins at an initial rate of 1mL/min for first 15mins, then increase to ~3mL/min for the remainder. <100kg: 0.3mg/kg once every 3 weeks. ≥100kg: 30mg once every 3 weeks.
Children
Not established.
Onpattro Contraindications
Not Applicable
Onpattro Boxed Warnings
Not Applicable
Onpattro Warnings/Precautions
Warnings/Precautions
Monitor for infusion-related reactions during infusion; consider slowing or interrupting infusion as clinically indicated; discontinue and do not resume if serious or life-threatening reaction occurs. Monitor infusion site for possible infiltration during infusion; manage suspected extravasation accordingly. Reduced serum Vit. A levels may develop; give supplementation at the recommended daily allowance of Vit. A. Refer patients for eye exam if ocular symptoms suggestive of Vit. A deficiency (eg, night blindness). Moderate or severe hepatic impairment: not studied. Severe renal impairment or ESRD: not studied. Pregnancy. Nursing mothers.
Onpattro Pharmacokinetics
See Literature
Onpattro Interactions
Not Applicable
Onpattro Adverse Reactions
Adverse Reactions
Upper respiratory tract infections, infusion-related reactions, dyspepsia, dyspnea, muscle spasms, arthralgia, erythema, bronchitis, vertigo.
Onpattro Clinical Trials
See Literature
Onpattro Note
Not Applicable
Onpattro Patient Counseling
See Literature
Onpattro Generic Name & Formulations
Legal Class
Rx
General Description
Patisiran 10mg/5mL (2mg/mL); per vial; lipid complex for IV infusion after filtration and dilution; preservative-free.
Pharmacological Class
Transthyretin-directed small interfering RNA.
How Supplied
Single-dose vial—1
Manufacturer
Generic Availability
NO
Onpattro Indications
Indications
Polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
Onpattro Dosage and Administration
Adult
See full labeling. Premedicate with IV corticosteroid, oral acetaminophen, IV H1- and H2-blocker on the day of Onpattro infusion
at least 60mins prior to initiation; may reduce corticosteroid as needed, if related adverse reactions occur. Give as IV infusion over ~80mins at an initial rate of 1mL/min for first 15mins, then increase to ~3mL/min for the remainder. <100kg: 0.3mg/kg once every 3 weeks. ≥100kg: 30mg once every 3 weeks.
Children
Not established.
Onpattro Contraindications
Not Applicable
Onpattro Boxed Warnings
Not Applicable
Onpattro Warnings/Precautions
Warnings/Precautions
Monitor for infusion-related reactions during infusion; consider slowing or interrupting infusion as clinically indicated; discontinue and do not resume if serious or life-threatening reaction occurs. Monitor infusion site for possible infiltration during infusion; manage suspected extravasation accordingly. Reduced serum Vit. A levels may develop; give supplementation at the recommended daily allowance of Vit. A. Refer patients for eye exam if ocular symptoms suggestive of Vit. A deficiency (eg, night blindness). Moderate or severe hepatic impairment: not studied. Severe renal impairment or ESRD: not studied. Pregnancy. Nursing mothers.
Onpattro Pharmacokinetics
See Literature
Onpattro Interactions
Not Applicable
Onpattro Adverse Reactions
Adverse Reactions
Upper respiratory tract infections, infusion-related reactions, dyspepsia, dyspnea, muscle spasms, arthralgia, erythema, bronchitis, vertigo.
Onpattro Clinical Trials
See Literature
Onpattro Note
Not Applicable
Onpattro Patient Counseling
See Literature
Images
